Insight Pharmaceuticals Issues A Voluntary Nationwide Recall Of ‘Nostrilla Nasal Decongestant’ Due To Bacterial Contamination

by Gary Kopycinski on October 21, 2011

Gary Kopycinski Author

More in Recalls:

Conagra Brands, Inc., Recalls Frozen Beef Products Due to Misbranding and Undeclared Allergens August 12, 2022
BrucePac Recalls Ready-to-Eat Chicken Sausage Products Due to Misbranding November 20, 2019
Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide Due to the Detection of Trace Amounts of NDEA November 14, 2018

Silver Spring, Maryland–(ENEWSPF)–October 20, 2011. Insight Pharmaceuticals, LLC of Langhorne, Pa., is recalling one lot (34,092 bottles) of Nostrilla Nasal Decongestant nasal spray to the consumer level, because it may contain the bacteria Burkholderia cepacia.